Aesthetic Medical Hldngs Group Research and Development Expenses 2019-2023 | AIH
Aesthetic Medical Hldngs Group research and development expenses from 2019 to 2023. Research and development expenses can be defined as an expense arising from studies and product development processes.
| Aesthetic Medical Hldngs Group Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2022 | $ |
| 2021 | $ |
| 2020 | $ |
| 2019 | $ |
| 2018 | $ |
| Aesthetic Medical Hldngs Group Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-09-30 | |
| 2019-06-30 | |
| 2018-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.015B | $0.096B |
| Aesthetic Medical International Holdings Group Limited provides aesthetic medical services. It offers surgical aesthetic treatments, such as eye and nose surgery, breast augmentation, liposuction and non-surgical aesthetic treatments. Aesthetic Medical International Holdings Group Limited is based in Shenzhen, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $123.960B | 15.55 |
| Cencora (COR) | United States | $44.706B | 17.43 |
| ICON (ICLR) | Ireland | $25.718B | 24.28 |
| DiDi Global (DIDIY) | China | $23.622B | 0.00 |
| Avantor (AVTR) | United States | $16.493B | 24.28 |
| CochLear (CHEOY) | Australia | $14.172B | 0.00 |
| Viatris (VTRS) | United States | $14.062B | 4.04 |
| Revvity (RVTY) | United States | $12.689B | 22.26 |
| Charles River Laboratories (CRL) | United States | $12.120B | 22.09 |
| Medpace Holdings (MEDP) | United States | $12.009B | 39.51 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.810B | 0.00 |
| Natera (NTRA) | United States | $11.552B | 0.00 |
| Solventum (SOLV) | United States | $11.460B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.363B | 0.00 |
| HealthEquity (HQY) | United States | $6.693B | 50.01 |
| Organon (OGN) | United States | $5.239B | 4.97 |
| Bausch + Lomb (BLCO) | Canada | $5.204B | 20.86 |
| Doximity (DOCS) | United States | $4.455B | 33.17 |
| PACS (PACS) | United States | $3.704B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.453B | 31.59 |
| Sotera Health (SHC) | United States | $3.175B | 15.58 |
| Progyny (PGNY) | United States | $3.091B | 51.87 |
| GoodRx Holdings (GDRX) | United States | $3.006B | 152.20 |
| Life Times (LTH) | United States | $2.911B | 30.50 |
| Premier (PINC) | United States | $2.350B | 8.79 |
| AMN Healthcare Services Inc (AMN) | United States | $2.284B | 7.39 |
| Agilon Health (AGL) | United States | $2.134B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.069B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.948B | 0.00 |
| NovoCure (NVCR) | Jersey | $1.725B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.407B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $1.296B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.715B | 7.59 |
| QDM (QDMI) | Hong Kong, SAR China | $0.703B | 18.40 |
| Embecta (EMBC) | United States | $0.591B | 3.90 |
| InnovAge Holding (INNV) | United States | $0.579B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.548B | 0.00 |
| CareDx (CDNA) | United States | $0.527B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.527B | 0.00 |
| LifeMD (LFMD) | United States | $0.504B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.503B | 0.00 |
| Enhabit (EHAB) | United States | $0.487B | 48.50 |
| Sonida Senior Living (SNDA) | United States | $0.454B | 0.00 |
| Beauty Health (SKIN) | United States | $0.423B | 0.00 |
| MultiPlan (MPLN) | United States | $0.391B | 0.00 |
| ModivCare (MODV) | United States | $0.373B | 6.99 |
| DocGo (DCGO) | United States | $0.365B | 19.44 |
| Sera Prognostics (SERA) | United States | $0.302B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.264B | 0.00 |
| Sharecare (SHCR) | United States | $0.250B | 0.00 |
| Biodesix (BDSX) | United States | $0.178B | 0.00 |
| So-Young (SY) | China | $0.137B | 46.00 |
| Oncology Institute (TOI) | United States | $0.068B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.053B | 0.00 |
| NeueHealth (NEUE) | United States | $0.053B | 7.13 |
| Co-Diagnostics (CODX) | United States | $0.038B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.033B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.032B | 0.00 |
| Nutex Health (NUTX) | United States | $0.032B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| OncoCyte (OCX) | United States | $0.023B | 0.00 |
| DermTech (DMTK) | United States | $0.022B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.006B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |